PT1448181E - Composicao farmaceutica compreendendo uma combinacao de metformina de um acido 4-oxobutanoico e o seu uso no tratamento da diabetes - Google Patents
Composicao farmaceutica compreendendo uma combinacao de metformina de um acido 4-oxobutanoico e o seu uso no tratamento da diabetesInfo
- Publication number
- PT1448181E PT1448181E PT02787576T PT02787576T PT1448181E PT 1448181 E PT1448181 E PT 1448181E PT 02787576 T PT02787576 T PT 02787576T PT 02787576 T PT02787576 T PT 02787576T PT 1448181 E PT1448181 E PT 1448181E
- Authority
- PT
- Portugal
- Prior art keywords
- alkyl
- aryl
- diabetes
- pharmaceutical composition
- treatment
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Diabetes (AREA)
- Epidemiology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Cardiology (AREA)
- Neurology (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Biomedical Technology (AREA)
- Vascular Medicine (AREA)
- Neurosurgery (AREA)
- Child & Adolescent Psychology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
- Furan Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0115398A FR2832633B1 (fr) | 2001-11-28 | 2001-11-28 | Composition pharmaceutique comprenant une association metformine et un acide 4-oxo-butanoique et son utilisation pour traiter le diabete |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT1448181E true PT1448181E (pt) | 2006-10-31 |
Family
ID=8869889
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT02787576T PT1448181E (pt) | 2001-11-28 | 2002-11-06 | Composicao farmaceutica compreendendo uma combinacao de metformina de um acido 4-oxobutanoico e o seu uso no tratamento da diabetes |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US20050020609A1 (pt) |
| EP (1) | EP1448181B1 (pt) |
| JP (1) | JP2005515984A (pt) |
| KR (1) | KR20040058266A (pt) |
| CN (1) | CN1592615A (pt) |
| AT (1) | ATE327746T1 (pt) |
| AU (1) | AU2002351848A1 (pt) |
| BR (1) | BR0214487A (pt) |
| CA (1) | CA2468280A1 (pt) |
| CY (1) | CY1105165T1 (pt) |
| DE (1) | DE60211938T2 (pt) |
| DK (1) | DK1448181T3 (pt) |
| ES (1) | ES2266605T3 (pt) |
| FR (1) | FR2832633B1 (pt) |
| HU (1) | HUP0402241A2 (pt) |
| MX (1) | MXPA04005033A (pt) |
| PL (1) | PL369894A1 (pt) |
| PT (1) | PT1448181E (pt) |
| RU (1) | RU2004119817A (pt) |
| TW (1) | TW200300341A (pt) |
| WO (1) | WO2003045368A1 (pt) |
| ZA (1) | ZA200405021B (pt) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPWO2005117855A1 (ja) * | 2004-06-04 | 2008-04-03 | 興和株式会社 | 糖尿病の予防または治療のための薬剤 |
| EP1792580A1 (en) | 2005-09-27 | 2007-06-06 | Ziterion GmbH | Two-part dental implants made of biocompatible ceramics |
| EP1967157A1 (en) | 2007-03-05 | 2008-09-10 | Ziterion GmbH | Hybrid two-part dental implant |
| EP2106767A1 (en) | 2008-03-31 | 2009-10-07 | Ziterion GmbH | Two-part dental implant |
| GB201004058D0 (en) * | 2010-03-11 | 2010-04-28 | Consiglio Nazionale Ricerche | Diagnostic assay for obesity and related disorders |
| JP7527275B2 (ja) * | 2018-09-28 | 2024-08-02 | ソシエテ・デ・プロデュイ・ネスレ・エス・アー | メトホルミンの作用を増強する化合物 |
| CN114349665B (zh) * | 2021-11-30 | 2023-06-09 | 潍坊博创国际生物医药研究院 | 二甲双胍焦谷氨酸晶体及其制备方法与应用 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5863915A (en) * | 1996-05-15 | 1999-01-26 | Bayer Corporation | Substituted 4-arylbutyric acid derivatives as matrix metalloprotease |
| FR2752422B1 (fr) * | 1996-08-16 | 1998-11-06 | Lipha | Composition pharmaceutique contenant des acides 4-oxo-butanoiques |
| US6011049A (en) * | 1997-02-19 | 2000-01-04 | Warner-Lambert Company | Combinations for diabetes |
| GB9922710D0 (en) * | 1999-09-24 | 1999-11-24 | Bayer Ag | Use of substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatatives for the treatment of multiple sclerosis |
| US6296874B1 (en) * | 2000-05-01 | 2001-10-02 | Aeropharm Technology Incorporated | Core formulation comprising troglitazone and abiguanide |
-
2001
- 2001-11-28 FR FR0115398A patent/FR2832633B1/fr not_active Expired - Fee Related
-
2002
- 2002-11-06 CA CA002468280A patent/CA2468280A1/en not_active Abandoned
- 2002-11-06 AT AT02787576T patent/ATE327746T1/de not_active IP Right Cessation
- 2002-11-06 BR BR0214487-5A patent/BR0214487A/pt not_active IP Right Cessation
- 2002-11-06 ES ES02787576T patent/ES2266605T3/es not_active Expired - Lifetime
- 2002-11-06 DK DK02787576T patent/DK1448181T3/da active
- 2002-11-06 WO PCT/EP2002/012355 patent/WO2003045368A1/en active IP Right Grant
- 2002-11-06 RU RU2004119817/15A patent/RU2004119817A/ru not_active Application Discontinuation
- 2002-11-06 PL PL02369894A patent/PL369894A1/xx not_active Application Discontinuation
- 2002-11-06 HU HU0402241A patent/HUP0402241A2/hu unknown
- 2002-11-06 PT PT02787576T patent/PT1448181E/pt unknown
- 2002-11-06 JP JP2003546870A patent/JP2005515984A/ja active Pending
- 2002-11-06 EP EP02787576A patent/EP1448181B1/en not_active Expired - Lifetime
- 2002-11-06 CN CNA028228375A patent/CN1592615A/zh active Pending
- 2002-11-06 AU AU2002351848A patent/AU2002351848A1/en not_active Abandoned
- 2002-11-06 KR KR10-2004-7006791A patent/KR20040058266A/ko not_active Application Discontinuation
- 2002-11-06 MX MXPA04005033A patent/MXPA04005033A/es not_active Application Discontinuation
- 2002-11-06 US US10/497,145 patent/US20050020609A1/en not_active Abandoned
- 2002-11-06 DE DE60211938T patent/DE60211938T2/de not_active Expired - Fee Related
- 2002-11-22 TW TW091134094A patent/TW200300341A/zh unknown
-
2004
- 2004-06-24 ZA ZA200405021A patent/ZA200405021B/en unknown
-
2006
- 2006-08-23 CY CY20061101178T patent/CY1105165T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ZA200405021B (en) | 2005-05-30 |
| HUP0402241A2 (hu) | 2005-02-28 |
| BR0214487A (pt) | 2004-10-19 |
| DK1448181T3 (da) | 2006-09-04 |
| ES2266605T3 (es) | 2007-03-01 |
| EP1448181B1 (en) | 2006-05-31 |
| FR2832633A1 (fr) | 2003-05-30 |
| FR2832633B1 (fr) | 2004-09-24 |
| EP1448181A1 (en) | 2004-08-25 |
| CA2468280A1 (en) | 2003-06-05 |
| KR20040058266A (ko) | 2004-07-03 |
| DE60211938T2 (de) | 2007-05-24 |
| AU2002351848A1 (en) | 2003-06-10 |
| US20050020609A1 (en) | 2005-01-27 |
| ATE327746T1 (de) | 2006-06-15 |
| WO2003045368A1 (en) | 2003-06-05 |
| CN1592615A (zh) | 2005-03-09 |
| TW200300341A (en) | 2003-06-01 |
| MXPA04005033A (es) | 2004-08-11 |
| PL369894A1 (en) | 2005-05-02 |
| CY1105165T1 (el) | 2010-03-03 |
| RU2004119817A (ru) | 2005-04-20 |
| JP2005515984A (ja) | 2005-06-02 |
| DE60211938D1 (de) | 2006-07-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20024177L (no) | Farmasöytiske preparater inneholdende azetidinderivater, de nye azetidinderivater og deres fremstilling | |
| RU2003120080A (ru) | Орто-замещенные азотсодержащие бисарильные соединения для применения в качестве ингибиторов калиевого канала, а также содержащие их фармацевтические композиции | |
| WO2007066189A3 (en) | Salts, prodrugs and formulations of 1-[5-(4-amino-7-isopropyl-7h-pyrrolo[2,3-d]pyrimidine-5-carbonyl)-2-methoxy-phenyl]-3-(2,4-dichloro-phenyl)-urea | |
| DK2314582T3 (da) | Heterocykliske forbindelser som antivirusmidler | |
| BRPI0415758A (pt) | combinações de substáncias ativas fungicidas sinergìsticas | |
| ATE448199T1 (de) | Verbindungen mit taxol-verstärkender wirkung | |
| WO2006056711A3 (fr) | Medicament oral a liberation modifiee d'au moins un principe actif sous forme multimicrocapsulaire | |
| ATE223378T1 (de) | Prolineamid-derivate | |
| NO20052130L (no) | Sterk inhibitor for HCV-serin-protease | |
| AR032781A1 (es) | Amidas ariladas de acidos furan- y tiofencarboxilicos, composiciones farmaceuticas, su utilizacion para la preparacion de medicamento como tambien las composiciones farmaceuticas que las contienen | |
| AR042658A1 (es) | Derivados de 1,5-diaril-pirrol-3-carboxamida y su uso como moduladores de receptores canabinoides | |
| DK2017276T3 (da) | Phenylcarboxamid-forbindelser til behandling af smerte | |
| BRPI0408727A (pt) | composto, processo para preparar o mesmo, composição farmacêutica, método para tratar de uma condição ou estado de doença mediados pela atividade da quinase p38 ou mediados pelas citocinas produzidas pela atividade da quinase p38, e, uso de um composto | |
| PT1448181E (pt) | Composicao farmaceutica compreendendo uma combinacao de metformina de um acido 4-oxobutanoico e o seu uso no tratamento da diabetes | |
| EP1314719A4 (en) | BENZOIC ACID DERIVATIVES AND MEDICAMENTS HAVING THE SAME AS ACTIVE INGREDIENT | |
| RU2010136061A (ru) | Производные арилсульфонамидозамещенной гидроксамовой кислоты в качестве ингибиторов металлопротеиназ матрикса | |
| ATE364586T1 (de) | Steigerung der wirksamkeit von wirkstoffen durch micellare zubereitung mit retinolderivaten | |
| SE0002476D0 (sv) | New compounds | |
| EA200701805A1 (ru) | Состав аэрозоля для дозирующих ингаляторов под давлением | |
| WO2002064552A8 (en) | 1g(a)-AMINO-N-HYDROXY-ACETAMIDE DERIVATIVES | |
| EA200300272A1 (ru) | Новые производные хиназолина, способ их получения и фармацевтические композиции, содержащие их | |
| DE60230629D1 (de) | Verwendung von 2,5-dihydroxybenzolsulfonsäure-derivaten bei der herstellung eines medikaments zur verstärkung der wirkung anderer arzneimittel zur behandlung der erektilen dysfunktion | |
| CA2411418A1 (en) | Hydroxyformamidine derivatives and medicines containing the same | |
| ATE352317T1 (de) | Therapeutische behandlung von eosinophilie durch verwendung von chymase-inhibitoren als aktiven bestandteilen | |
| DE60233715D1 (de) | Mittel zur behandlung des haares |